For pediatric patients 6 to 14 years of age: one 5-mg chewable tablet. The dose of prazosin should be adjusted based on the individual patient response. The dose of MINIPRESS should be adjusted according to the patient's individual blood pressure response. Patients who miss a dose should take the next dose at their regular time and should not take 2 doses at the same time.Patients who miss a dose should take the next dose at their regular time and should not take 2 doses at the same time.Patients who miss a dose should take the next dose at their regular time and should not take 2 doses at the same time.We comply with the HONcode standard for trustworthy health information - An additional dose of SINGULAIR should not be taken within 24 hours of a previous dose.
Available for Android and iOS devices. The Food and Drug Administration (FDA) announced late last week that the allergy and asthma drug montelukast, sold under the brand named Singulair, will carry a new boxed warning. Select one or more newsletters to continue. The following doses are recommended:For adults and adolescents 15 years of age and older: one 10-mg tablet.For pediatric patients 6 to 14 years of age: one 5-mg chewable tablet.An additional dose of SINGULAIR should not be taken within 24 hours of a previous dose.
Efficacy has been demonstrated for asthma when montelukast was administered in the evening without regard to time of food ingestion.For prevention of EIB, a single dose of SINGULAIR should be taken at least 2 hours before exercise. SINGULAIR should be taken once daily in the evening. Rescue medications (e.g., beta-agonists) should be available. The time of administration may be individualized to suit patient needs.The following doses for the treatment of symptoms of seasonal allergic rhinitis are recommended:For adults and adolescents 15 years of age and older: one 10-mg tablet.For pediatric patients 6 to 14 years of age: one 5-mg chewable tablet.For pediatric patients 2 to 5 years of age: one 4-mg chewable tablet or one packet of 4-mg oral granules.Safety and effectiveness in pediatric patients younger than 2 years of age with seasonal allergic rhinitis have not been established.The following doses for the treatment of symptoms of perennial allergic rhinitis are recommended:For adults and adolescents 15 years of age and older: one 10-mg tablet.For pediatric patients 6 to 14 years of age: one 5-mg chewable tablet.For pediatric patients 2 to 5 years of age: one 4-mg chewable tablet or one packet of 4-mg oral granules.For pediatric patients 6 to 23 months of age: one packet of 4-mg oral granules.Safety and effectiveness in pediatric patients younger than 6 months of age with perennial allergic rhinitis have not been established.Patients with both asthma and allergic rhinitis should take only one SINGULAIR dose daily in the evening.SINGULAIR 4-mg oral granules can be administered either directly in the mouth, dissolved in 1 teaspoonful (5 mL) of cold or room temperature baby formula or breast milk, or mixed with a spoonful of cold or room temperature soft foods; based on stability studies, only applesauce, carrots, rice, or ice cream should be used.
The therapeutic dosages most commonly employed have ranged from 6 mg to 15 mg daily given in divided doses. Safety and efficacy in patients younger than 6 years of age have not been established. Patients already taking SINGULAIR daily for another indication (including chronic asthma) should not take an additional dose to prevent EIB. The dose of MINIPRESS should be adjusted according to the patient's individual blood pressure response. The following doses are recommended:For adults and adolescents 15 years of age and older: one 10-mg tablet.For pediatric patients 6 to 14 years of age: one 5-mg chewable tablet.For pediatric patients 2 to 5 years of age: one 4-mg chewable tablet or one packet of 4-mg oral granules.For pediatric patients 12 to 23 months of age: one packet of 4-mg oral granules.Safety and effectiveness in pediatric patients less than 12 months of age with asthma have not been established.There have been no clinical trials in patients with asthma to evaluate the relative efficacy of morning versus evening dosing. To decrease the risk of orthostatic hypotension the first dose may be given at bedtime. All patients should have available for rescue a short-acting β-agonist. After initial titration some patients can be maintained adequately on a twice daily dosage regimen.When adding a diuretic or other antihypertensive agent, the dose of MINIPRESS should be reduced to 1 mg or 2 mg three times a day and retitration then carried out.Concomitant administration of MINIPRESS with a PDE-5 inhibitor can result in additive blood pressure lowering effects and symptomatic hypotension; therefore, PDE-5 inhibitor therapy should be initiated at the lowest dose in patients taking MINIPRESS.Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records.